UPS - Concerns of chelation therapy, autism

[Guest guest]

Concerns of chelation therapy, autism

ITHACA, N.Y., Dec. 14 (UPI) -- Lead chelation therapy reduces lead exposure problems but could create lasting effects for children treated for autism, say New York researchers.

Cornell University researchers say their study in young rats has implications for the treatment of autistic children, because when rats with no lead in their systems were treated with the lead-removing chemical, they showed declines in their learning and behavior that were similar to the rats that were exposed to lead.

Chelating drugs, which bind to lead and other metals in the blood, are increasingly being used for the treatment of autism in children.

The rats with moderate lead exposure benefited greatly from the lead chelation medication succimer, and rats exposed to higher lead levels showed benefits in the emotional domain; however, for the control group with no lead exposure that were given succimer, "we found lasting cognition and emotion-regulation (deficits) that were as pervasive and large as rats with high lead exposure," according to the study published in the journal Environmental Health Perspectives.

One possibility is that succimer, in the absence of lead, may disrupt the balance of such essential minerals as zinc and iron.

"These findings raise concerns about the use of chelating agents in treating autistic children," said senior author Barbara Strupp.

[Guest guest]

>

> Yeah, that's right! FAR better to give them Ritalin or some other

big pharma company drug. It has NO side effects !!(LOL) Just as well

we have the medical establishment to keep us right and to keep all

the big pharmaceutical companies in business.

Not to mention the down side of just leaving mercury and lead in our

children's systems.

This is why one consistently monitors the balance of all mineral and

trace elements when chelating in addition to the levels excreted

through porphyrin and OAT tests.

Do these researchers have nothing better to do?

Rhona

> Concerns of chelation therapy, autism

> ITHACA, N.Y., Dec. 14 (UPI) -- Lead chelation therapy reduces lead

exposure

> problems but could create lasting effects for children treated for

autism,

> say New York researchers.

> Cornell University researchers say their study in young rats has

implications

> for the treatment of autistic children, because when rats with no

lead in

> their systems were treated with the lead-removing chemical, they

showed

> declines in their learning and behavior that were similar to the

rats that were

> exposed to lead.

> Chelating drugs, which bind to lead and other metals in the blood,

are

> increasingly being used for the treatment of autism in children.

> The rats with moderate lead exposure benefited greatly from the

lead

> chelation medication succimer, and rats exposed to higher lead

levels showed

> benefits in the emotional domain; however, for the control group

with no lead

> exposure that were given succimer, " we found lasting cognition and

> emotion-regulation (deficits) that were as pervasive and large as

rats with high lead

> exposure, " according to the study published in the journal

Environmental Health

> Perspectives.

> One possibility is that succimer, in the absence of lead, may

disrupt the

> balance of such essential minerals as zinc and iron.

> " These findings raise concerns about the use of chelating agents in

treating

> autistic children, " said senior author Barbara Strupp.

>

[Guest guest]

I perefer this one:

http://www.newswise.com/articles/view/525949/

the same story, not the same point of view...

Liora

>

>

> Concerns of chelation therapy, autism

> ITHACA, N.Y., Dec. 14 (UPI) -- Lead chelation therapy reduces

lead exposure

> problems but could create lasting effects for children treated

for autism,

> say New York researchers.

> Cornell University researchers say their study in young rats has

implications

> for the treatment of autistic children, because when rats with no

lead in

> their systems were treated with the lead-removing chemical, they

showed

> declines in their learning and behavior that were similar to the

rats that were

> exposed to lead.

> Chelating drugs, which bind to lead and other metals in the blood,

are

> increasingly being used for the treatment of autism in children.

> The rats with moderate lead exposure benefited greatly from the

lead

> chelation medication succimer, and rats exposed to higher lead

levels showed

> benefits in the emotional domain; however, for the control group

with no lead

> exposure that were given succimer, " we found lasting cognition

and

> emotion-regulation (deficits) that were as pervasive and large as

rats with high lead

> exposure, " according to the study published in the journal

Environmental Health

> Perspectives.

> One possibility is that succimer, in the absence of lead, may

disrupt the

> balance of such essential minerals as zinc and iron.

> " These findings raise concerns about the use of chelating agents

in treating

> autistic children, " said senior author Barbara Strupp.

>